Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant cell line produces adenoviral gene products E1 and DEF-A, and/or DEF-B

Recombinant cell line produces adenoviral gene products E1 and DEF-A, and/or DEF-B

US Patent 6458578 · Granted Oct 1, 2002

Estimated economic value: $1,366,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Human papillomavirus vaccines and uses of the same2025
Hepatitis B vaccines and uses of the same2025
Hepatitis B vaccines and uses of the same2023
Simian (gorilla) adenovirus or adenoviral vectors and methods of use2022
Adenoviral vector encoding human atonal homolog-1 (HATH1)2022
Adenovectors for delivery of therapeutic genetic material into T cells2021
Affenadenovirus (gorilla) or adenoviral vectors and methods of use2021
Modified serotype 28 adenoviral vectors2021
Affenadenovirus (gorilla) or adenoviral vectors and methods of use2020
Simian (gorilla) adenovirus or adenoviral vectors and methods of use2020
Malaria antigens and methods of use2020
Method for propagating adenoviral vectors encoding inhibitory gene products2020